Page last updated: 2024-10-25

ciprofibrate and HIV Coinfection

ciprofibrate has been researched along with HIV Coinfection in 2 studies

Research Excerpts

ExcerptRelevanceReference
"To demonstrate the effectiveness and safety of rosuvastatin and ciprofibrate in the treatment of dyslipidemia associated with highly active antiretroviral therapy in patients with HIV."7.78Rosuvastatin and ciprofibrate in the treatment of dyslipidemia in patients with HIV. ( Cunha, RV; Domingos, H; Domingos, JA; Paniago, AM; Rodrigues, RL; Souza, AS, 2012)
"To demonstrate the effectiveness and safety of rosuvastatin and ciprofibrate in the treatment of dyslipidemia associated with highly active antiretroviral therapy in patients with HIV."3.78Rosuvastatin and ciprofibrate in the treatment of dyslipidemia in patients with HIV. ( Cunha, RV; Domingos, H; Domingos, JA; Paniago, AM; Rodrigues, RL; Souza, AS, 2012)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Domingos, H1
Cunha, RV1
Paniago, AM1
Souza, AS1
Rodrigues, RL1
Domingos, JA1
Fontaine, C1
Guiard-Schmid, JB1
Slama, L1
Essid, A1
Lukiana, T1
Rondeau, E1
Pialoux, G1

Other Studies

2 other studies available for ciprofibrate and HIV Coinfection

ArticleYear
Rosuvastatin and ciprofibrate in the treatment of dyslipidemia in patients with HIV.
    Arquivos brasileiros de cardiologia, 2012, Volume: 99, Issue:5

    Topics: Adult; Antiretroviral Therapy, Highly Active; Cardiovascular Diseases; Cholesterol; Dyslipidemias; F

2012
Severe rhabdomyolysis during a hypersensitivity reaction to abacavir in a patient treated with ciprofibrate.
    AIDS (London, England), 2005, Nov-04, Volume: 19, Issue:16

    Topics: Anti-HIV Agents; Clofibric Acid; Dideoxynucleosides; Drug Hypersensitivity; Drug Interactions; Drug

2005